Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

65.94
Delayed Data
As of Apr 28
 -0.13 / -0.20%
Today’s Change
55.06
Today|||52-Week Range
68.12
+5.30%
Year-to-Date
AbbVie Reports Humira Sales Growth in 1st Quarter
Apr 28 / GuruFocus News - Paid Partner Content
AbbVie (ABBV) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Apr 27 / Zacks.com - Paid Partner Content
Cadence Bank Na Buys Wyndham Worldwide, Host Hotels & Resorts, GGP, Sells Schlumberge...
Apr 28 / GuruFocus News - Paid Partner Content
Hennessy Advisors Inc Buys VF, Coca-Cola Co, Plains GP Holdings LP, Sells Spectra Ene...
Apr 27 / GuruFocus News - Paid Partner Content
LaFleur & Godfrey LLC Buys Vulcan Materials Co, Copart, Apache, Sells AbbVie, Harman ...
Apr 28 / GuruFocus News - Paid Partner Content
AbbVie Is Flexing Its Abs
Apr 27 / TheStreet.com - Paid Partner Content
AbbVie's Humira Revenue Up 15% Despite Patent Cliff Fears
Apr 28 / GuruFocus News - Paid Partner Content
AbbVie (ABBV) Beats Earnings and Revenue in Q1
Apr 27 / Zacks.com - Paid Partner Content
Cramer: When Oil Falls, These Dominoes Get Hit
Apr 27 / TheStreet.com - Paid Partner Content
A Trio of Stocks Up on Nice Results
Apr 27 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close66.07
Today’s open66.06
Day’s range65.44 - 66.32
Volume5,521,146
Average volume (3 months)6,483,468
Market cap$105.1B
Dividend yield3.88%
Data as of 4:01pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+14.40%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+12.16%
P/E ratio18.2
Price/Sales3.98
Price/Book22.65

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.12+0.29%
CELGCelgene+0.08+0.06%
BMYBristol-Myers Squibb+0.38+0.68%
----
Data as of 4:02pm ET, 04/28/2017

Financials

Last reporting dateApril 27, 2017
EPS forecast (this quarter)$1.26
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts